Prevention and treatment of acute renal failure: Significance of metabolic interventions;Prävention und therapie des akuten nierenversagens: Bedeutung metabolischer interventionen

Wiener Klinische Wochenschrift

Volumn 119, Issue 7-8, 2007, Pages 201-204

  Druml, Wilfred ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Acute renal failure; Metabolic interventions; Metabolism

Indexed keywords

ACETYLCYSTEINE; DIURETIC AGENT; ESSENTIAL AMINO ACID; GLUCOSE;

ACUTE KIDNEY FAILURE; BLOOD VOLUME; CREATININE CLEARANCE; EDITORIAL; HEMATOCRIT; HEPATORENAL SYNDROME; HUMAN; HYPERGLYCEMIA; HYPOKALEMIA; HYPOPHOSPHATEMIA; MULTIPLE ORGAN FAILURE; NONHUMAN; PROGNOSIS; RENAL PROTECTION; SEPSIS; STEM CELL TRANSPLANTATION; VASOCONSTRICTION; VASODILATATION;

AMINO ACIDS; DIURESIS; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY; KIDNEY FAILURE, ACUTE; NITROGEN;

EID: 34250204860     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-007-0793-4     Document Type: Editorial

References (29)

1. Lameire N, Van Biesen W, Vanholder R (2005) Acute renal failure. Lancet 365: 417-430
2. Abel RM, Beck CH Jr, Abbott WM, Ryan JA Jr, Barnett GO, Fischer JE (1973) Improved survival from acute renal failure after treatment with intravenous essential L-amino acids and glucose. Results of a prospective, double-blind study. N Engl J Med 288: 695-699
3. Toback FG (1992) Regeneration after acute tubular necrosis. Kidney Int 41: 226-246
4. Zager RA (1987) Amino acid hyperalimentation in acute renal failure: a potential therapeutic paradox. Kidney Int Suppl 22: S72-75
5. Moursi M, Rising CL, Zelenock GB, D'Alecy LG (1987) Dextrose administration exacerbates acute renal ischemic damage in anesthetized dogs. Arch Surg 122: 790-794
6. Racusen LC, Finn WF, Whelton A, Solez K (1985) Mechanisms of lysine-induced acute renal failure in rats. Kidney Int 27: 517-522
7. Barone R, Pauwels S, De Camps J, Krenning EP, Kvols LK, Smith MC, Bouterfa H, Devuyst O, Jamar F (2004) Metabolic effects of amino acid solutions infused for renal protection during therapy with radiolabelled somatostatin analogues. Nephrol Dial Transplant 19: 2275-2281
8. Brundin T, Wahren J (1994) Renal oxygen consumption, thermogenesis, and amino acid utilization during i.v. infusion of amino acids in man. Am J Physiol 267: E648-655
9. Schramm L, Weierich T, Heldbreder E, Zimmermann J, Netzer KO, Wanner C (2005) Endotoxin-induced acute renal failure in rats: effects of L-arginine and nitric oxide synthase inhibition on renal function. J Nephrol 18: 374-381
10. Welbourne T, Claville W, Langford M (1998) An oral glutamine load enhances renal acid secretion and function. Am J Clin Nutr 67: 660-663
11. Griffiths RD, Jones C, Palmer TE (1997) Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 13: 295-302
12. Badalamenti S, Gines P, Arroyo V, Llach J, Piera C, Rimola A, Jimenez W, Gaya J, Casamitjana R, Rivera F, et al (1990) Effects of intravenous amino acid infusion and dietary proteins on kidney function in cirrhosis. Hepatology 11: 379-386
13. Pons M, Plante I, LeBrun M, Gourde P, Simard M, Grenier L, Thibault L, Labrecque G, Beauchamp D (2003) Protein-rich diet attenuates cyclosporin A-induced renal tubular damage in rats. J Ren Nutr 13: 84-92
14. Singer P (2007) High-dose amino acid infusion preserves diuresis and improves nitrogen balance in non-oliguric acute renal failure. Wien Klin Wochenschr 119: 218-222
15. Reddy DR, Prabhakar V, Rao BD (1971) Tube feeding syndrome (protein intoxication), (a report of three cases). Neurol India 19: 102-106
16. Roberts PR, Black KW, Zaloga GP (1997) Enteral feeding improves outcome and protects against glycerol-induced acute renal failure in the rat. Am J Respir Crit Care Med 156: 1265-1269
17. Mouser JF, Hak EB, Kuhl DA, Dickerson RN, Gaber LW, Hak LJ (1997) Recovery from ischemic acute renal failure is improved with enteral compared with parenteral nutrition. Crit Care Med 25: 1748-1754
18. Metnitz PG, Krenn CG, Steltzer H, Lang T, Ploder J, Lenz K, Le Gall JR, Druml W (2002) Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 30: 2051-2058
19. Hirschberg R, Kopple J, Lipsett P, Benjamin E, Minei J, Albertson T, Munger M, Metzler M, Zaloga G, Murray M, Lowry S, Conger J, McKeown W, O'Shea M, Baughman R, Wood K, Haupt M, Kaiser R, Simms H, Warnock D, Summer W, Hintz R, Myers B, Haenftling K, Capra W, et al (1999) Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 55: 2423-2432
20. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ (1999) Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 341: 785-792
21. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P (2003) Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31: 359-366
22. Das UN (2001) Is insulin an antiinflammatory molecule? Nutrition 17: 409-413
23. Metnitz GH, Fischer M, Bartens C, Steltzer H, Lang T, Druml W (2000) Impact of acute renal failure on antioxidant status in multiple organ failure. Acta Anaesthesiol Scand 44: 236-240
24. Nathens AB, Neff MJ, Jurkovich GJ, Klotz P, Farver K, Ruzinski JT, Radella F, Garcia I, Maier RV (2002) Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 236: 814-822
25. Angstwurm MW, Schottdorf J, Schopohl J, Gaertner R (1999) Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med 27: 1807-1813
26. Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, Strauss R, Meier-Hellmann A, Insel R, Radke J, Schuttler J, Gartner R (2007) Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 35: 118-126
27. Komisarof JA, Gilkey GM, Peters DM, Koudelka CW, Meyer MM, Smith SM (2007) N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON). Crit Care Med 35: 435-441
28. Seguro AC, de Araujo M, Seguro FS, Rienzo M, Magaldi AJ, Campos SB (2003) Effects of hypokalemia and hypomagnesemia on zidovudine (AZT) and didanosine (ddI) nephrotoxicity in rats. Clin Nephrol 59: 267-272
29. Lumlertgul D, Harris DC, Burke TJ, Schrier RW (1986) Detrimental effect of hypophosphatemia on the severity and progression of ischemic acute renal failure. Miner Electrolyte Metab 12: 204-209